Morgan Stanley Upgrades Quantinuum to Overweight, Cuts Price Target
Morgan Stanley raised its rating on Quantinuum to Overweight from Equalweight but cut its price target from $78 to $62. Shares rose 3.42% in premarket trading.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.